Peter Klein Klouwenberg
Overview
Explore the profile of Peter Klein Klouwenberg including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
8
Citations
205
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Miller 3rd R, Lopansri B, Burke J, Levy M, Opal S, Rothman R, et al.
Am J Respir Crit Care Med
. 2018 Apr;
198(7):903-913.
PMID: 29624409
Rationale: A molecular test to distinguish between sepsis and systemic inflammation of noninfectious etiology could potentially have clinical utility. Objectives: This study evaluated the diagnostic performance of a molecular host...
2.
Klein Klouwenberg P, Sasi P, Bashraheil M, Awuondo K, Bonten M, Berkley J, et al.
PLoS One
. 2011 Jul;
6(7):e21013.
PMID: 21754982
Background: In sub-Saharan Africa, Plasmodium falciparum and hepatitis A (HAV) infections are common, especially in children. Co-infections with these two pathogens may therefore occur, but it is unknown if temporal...
3.
Klein Klouwenberg P, Tan L, Werkman W, van Bleek G, Coenjaerts F
Crit Rev Immunol
. 2010 Feb;
29(6):531-50.
PMID: 20121698
Toll-like receptors (TLRs) play a distinct role in battling respiratory syncytial virus (RSV) infections. However, due to a lack of representative animal models and several early controversies, the field is...
4.
Klein Klouwenberg P, Bont L
Clin Dev Immunol
. 2008 Oct;
2008:628963.
PMID: 18825269
Encapsulated bacteria are responsible for the majority of mortality among neonates and infants. The major components on the surface of these bacteria are polysaccharides which are important virulence factors. Immunity...
5.
Grobusch M, Lell B, Schwarz N, Gabor J, Dornemann J, Potschke M, et al.
J Infect Dis
. 2007 Nov;
196(11):1595-602.
PMID: 18008242
Background: Intermittent preventive treatment aims to maximize the protective effects of malaria chemoprophylaxis while minimizing the deleterious effects. Methods: In Gabon, 1189 infants received either sulfadoxine-pyrimethamine (SP; 250 and 12.5...
6.
Schwarz N, Oyakhirome S, Potschke M, Glaser B, Klein Klouwenberg P, Altun H, et al.
Am J Trop Med Hyg
. 2005 Oct;
73(4):705-9.
PMID: 16222013
Despite different recommendations from WHO and national authorities, artesunate monotherapy is increasingly used for treating African children with malaria. A 5-day course of oral artesunate (first day: 4 mg/kg body...
7.
Verbaan F, Klein Klouwenberg P, van Steenis J, Snel C, Boerman O, Hennink W, et al.
Int J Pharm
. 2005 Sep;
304(1-2):185-92.
PMID: 16129577
Previously, attempts were made in our laboratory to transfect human ovarian cancer (OVCAR-3) cells, growing in the peritoneal cavity of nude mice, by intraperitoneal administration of poly(2-(dimethylamino)ethyl methacrylate) (pDMAEMA)-based polyplexes....
8.
Ramharter M, Oyakhirome S, Klein Klouwenberg P, Adegnika A, Agnandji S, Missinou M, et al.
Clin Infect Dis
. 2005 May;
40(12):1777-84.
PMID: 15909266
Background: Artemisinin-based drug combinations are the mainstay in the fight against drug-resistant malaria in Africa. Currently available antimalarial drug combinations that include artemisinins are pharmacokinetically unmatched and are therefore potentially...